Jesse Salk
Jesse Salk is currently the Co-founder and CEO at TwinStrand Biosciences.
Kevin Conroy Resigns from Adaptive Biotechnologies Board; Tagboard COO Tyler Singletary Steps Down; Ron Andrews Named TwinStrand CEO
Kevin Conroy resigned from the board of Adaptive Biotechnologies, and Tagboard's COO Tyler Singletary is stepping down. Additionally, Ron Andrews was named CEO of TwinStrand Biosciences, while David Meininger stepped down as CEO of Link Immunotherapeutics.
TwinStrand Biosciences CEO Jesse Salk Steps Down Amid Layoffs; Chad Brown Named Interim CEO
TwinStrand Biosciences co-founder Jesse Salk has stepped down as CEO but will remain chief scientific officer and board member, with Chad Brown named interim CEO amid reported layoffs cutting nearly 50% of the workforce at the Seattle-based gene sequencing startup. The company, founded seven years ago and backed by a $50 million Series B round in 2021, declined to comment on the layoffs.
TwinStrand Biosciences, led by Jesse Salk, raises $50M Series B from Section 32 to scale ultra-accurate gene-sequencing
TwinStrand Biosciences, co-founded and led by Jesse Salk, raised $50 million in a Series B led by Section 32 to expand its high-accuracy gene-sequencing technology for detecting rare mutations with applications in cancer detection, therapy monitoring, and safety testing.
Phase Genomics CEO Ivan Liachko shifts company to R&D focus after pandemic hits revenue; one furlough, no layoffs
Phase Genomics, a five-year-old University of Washington spinoff led by CEO Ivan Liachko, shifted to skeleton lab crews and remote work during the pandemic, cutting revenue and furloughing one employee while focusing R&D inward to adapt and continue innovating. The company is adjusting its genomics technology amid Seattle's biotech disruption and exploring ways to help with COVID-19 research.
Organizations
-
TwinStrand Co-founder and CEO · current
